期刊
PHARMACOLOGY RESEARCH & PERSPECTIVES
卷 9, 期 1, 页码 -出版社
JOHN WILEY & SONS LTD
DOI: 10.1002/prp2.720
关键词
hepatocellular carcinoma; long noncoding RNA; miR-138-5p; oxaliplatin resistance; UCA1
资金
- Natural Science Foundation of Guangxi Province [2018GXNSFAA050053]
- key planning development research program of Guangxi [guikeAB16380215]
- Guangxi Natural Science Foundation [2017GXNSFAA198103]
- Innovation Project of Guangxi Graduate Education [YCBZ2020054]
- Guangxi First-class Discipline Project for Pharmaceutical Sciences [GXFCDP-PS-2018]
- Project of Innovation, Entrepreneurship, and Joint Training Base for Pharmaceutical Postgraduates
The study found that HCC patients with high levels of UCA1 had shorter survival time, and UCA1 may contribute to OXA resistance via miR-138-5p-mediated AKT/mTOR activation.
Hepatocellular carcinoma (HCC) inevitably developed oxaliplatin (OXA) resistance after long-term treatment, but the mechanism remains unclear. Here, we found that LncRNA UCA1 was upregulated in most of OXA-resistant HCC tissues and cells (HepG2/OXA and SMMC-7721/OXA). Follow-up analysis and online Kaplan-Meier Plotter revealed that HCC patients with high UCA1 level had a shorter survival compared with those with low expression. Overexpression of UCA1 increased OXA IC50 in HepG2 and SMMC-7721 cells, whereas knockdown of UCA1 decreased OXA IC50 in resistant counterparts. Moreover, dual luciferase reporter assay showed that co-transfection of UCA1-WT plasmid with miR-138-5p mimics enhanced fluorescence signals, whereas co-transfection of UCA1-Mut plasmid and miR-138-5p mimics did not induce any changes. Consistently, UCA1 levels in HepG2/OXA and SMMC-7721/OXA cells were downregulated after transfected with miR-138-5p mimics. UCA1 silencing or transfection of miR-138-5p mmics inhibited the activation of AKT and mTOR in HepG2/OXA and SMMC-7721/OXA cells, whereas UCA1 overexpression increased the phosphorylated AKT and mTOR levels in parental counterparts. Rapamycin or miR-138-5p mimics similarly suppressed the activation of AKT and mTOR, whereas UCA1 overexpression exert opposite roles. Interestingly, administration of rapamycin or miR-138-5p mimics apparently antagonized the effects of UCA1 on AKT and mTOR activation. Besides, depletion of UCA1 triggered more dramatic regression of HepG2 xenografts than that of HepG2/OXA xenografts with OXA treatment and impaired the p-AKT and p-mTOR levels in vivo. In conclusion, our findings provide the evidence that UCA1 may contribute to OXA resistance via miR-138-5p-mediated AK /mTOR activation, suggesting that UCA1 is a potential therapeutic target for HCC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据